| scholarly article | Q13442814 |
| P50 | author | David Altshuler | Q5230746 |
| Joel Hirschhorn | Q56277942 | ||
| Steven R DePalma | Q57036097 | ||
| Alexander G. Bick | Q57613503 | ||
| Birgit H Funke | Q86689117 | ||
| Jonathan G Seidman | Q88295024 | ||
| Christopher J O'Donnell | Q89928448 | ||
| Daniel C Herman | Q90335940 | ||
| James G. Wilson | Q92206045 | ||
| Herman A Taylor | Q97552746 | ||
| Namrata Gupta | Q114072729 | ||
| Jason Flannick | Q114332654 | ||
| Michael G Parfenov | Q114417683 | ||
| Jayashri R Aragam | Q114427805 | ||
| Emelia J. Benjamin | Q28754501 | ||
| Christine E. Seidman | Q30123970 | ||
| Ramachandran S. Vasan | Q30348351 | ||
| Stacey Gabriel | Q32649203 | ||
| Heidi L. Rehm | Q41543979 | ||
| Christopher Newton-Cheh | Q28039334 | ||
| Sekar Kathiresan | Q28050074 | ||
| P2093 | author name string | Susan Cheng | |
| Ervin R Fox | |||
| Kaoru Ito | |||
| P2860 | cites work | Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation | Q47301708 |
| Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? | Q47347230 | ||
| Association between fasting plasma glucose and left ventricular mass and left ventricular hypertrophy over 4 years in a healthy population aged 60 and older. | Q51471566 | ||
| The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study | Q67900385 | ||
| A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study | Q69987965 | ||
| The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation | Q74623264 | ||
| Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities | Q77766277 | ||
| Pooled association tests for rare variants in exon-resequencing studies | Q28743126 | ||
| A framework for variation discovery and genotyping using next-generation DNA sequencing data | Q29547262 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing | Q29614576 | ||
| Proportionally more deleterious genetic variation in European than in African populations. | Q30367885 | ||
| Testing for an unusual distribution of rare variants | Q33847792 | ||
| Genetics of hypertrophic cardiomyopathy | Q34101165 | ||
| Genetics of the Framingham Heart Study population | Q34458072 | ||
| Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings | Q34562725 | ||
| Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy | Q35589252 | ||
| Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS). | Q35801026 | ||
| Predicting the 30-year risk of cardiovascular disease: the framingham heart study | Q37356527 | ||
| Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study | Q37385696 | ||
| Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables. | Q39461431 | ||
| Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension | Q40736402 | ||
| Study design for genetic analysis in the Jackson Heart Study | Q46314519 | ||
| Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study | Q46459428 | ||
| Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study | Q24338862 | ||
| Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 513-519 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | American Journal of Human Genetics | Q4744249 |
| P1476 | title | Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts | |
| P478 | volume | 91 |
| Q35798392 | A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium). |
| Q103002725 | A state-based approach to genomics for rare disease and population screening |
| Q39199102 | Aggregate penetrance of genomic variants for actionable disorders in European and African Americans |
| Q33734037 | Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes |
| Q35021365 | Bayesian models for syndrome- and gene-specific probabilities of novel variant pathogenicity |
| Q30838224 | Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy |
| Q37497582 | Causality in genetics: the gradient of genetic effects and back to Koch's postulates of causality |
| Q30598629 | Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy |
| Q28075470 | Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy |
| Q42316395 | Commercial clinical genetic sequencing panels for evaluating patients with familial disease--are they ready for prime time? |
| Q27321601 | Complex genetic architecture of cardiac disease in a wild type inbred strain of Drosophila melanogaster |
| Q38125386 | Dilated cardiomyopathy: the complexity of a diverse genetic architecture. |
| Q36847480 | Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise. |
| Q39283141 | Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencing |
| Q52718355 | Enlightening the Association between Bicuspid Aortic Valve and Aortopathy. |
| Q89672741 | Exercise and hypertrophic cardiomyopathy: Two incompatible entities? |
| Q30393558 | Exploration of pathomechanisms triggered by a single-nucleotide polymorphism in titin's I-band: the cardiomyopathy-linked mutation T2580I. |
| Q26316693 | Genetic Misdiagnoses and the Potential for Health Disparities |
| Q38203394 | Genetic testing in cardiovascular diseases |
| Q27691994 | Genetics and disease of ventricular muscle |
| Q37594505 | Genetics and genetic testing of dilated cardiomyopathy: a new perspective. |
| Q38261314 | Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy |
| Q28655218 | Guidelines for investigating causality of sequence variants in human disease |
| Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
| Q42515078 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy |
| Q33167969 | Hypertrophic obstructive cardiomyopathy |
| Q56968727 | Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers |
| Q37696155 | Increased burden of cardiovascular disease in carriers of APOL1 genetic variants |
| Q48752307 | Individualized stem cell therapy |
| Q36027981 | Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease |
| Q38138883 | Mendelian forms of structural cardiovascular disease |
| Q42462379 | Modulation of hepatic mitochondrial energy efficiency with age. |
| Q64941423 | Molecular Epidemiology of Heart Failure: Translational Challenges and Opportunities. |
| Q89190941 | Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week |
| Q47579204 | Pharmacological and non-pharmacological treatment of obstructive hypertrophic cardiomyopathy |
| Q36902678 | Phenotypic extremes in rare variant study designs |
| Q37397192 | Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy |
| Q64069692 | Prevalence of Unexplained Left Ventricular Hypertrophy by Cardiac Magnetic Resonance Imaging in MESA |
| Q38741558 | Prognostic implications of left ventricular asymmetry in patients with asymptomatic aortic valve stenosis |
| Q36639581 | Quantifying prion disease penetrance using large population control cohorts |
| Q42317236 | Rare Association of two Genetic Causes of Sudden Death in a Young Survivor. |
| Q38245817 | Rare and low-frequency variants in human common diseases and other complex traits |
| Q27694507 | Research priorities in sarcomeric cardiomyopathies |
| Q30249495 | The Future of Genetics and Genomics: Closing the Phenotype Gap in Precision Medicine |
| Q30245043 | Update on hypertrophic cardiomyopathy and a guide to the guidelines. |
| Q35036043 | Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy |
| Q34497678 | Whole-genome sequencing of the world's oldest people |
Search more.